[Use of medication, supplements and natural products during pregnancy].


Journal

Laeknabladid
ISSN: 0023-7213
Titre abrégé: Laeknabladid
Pays: Iceland
ID NLM: 7901326

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 3 1 2019
pubmed: 3 1 2019
medline: 18 12 2019
Statut: ppublish

Résumé

Evidence-based information regarding the use of medication during pregnancy is lacking, even though the use of medication during pregnancy is considered common and often neccesary. The aim of this study was to obtain reliable information on the use of medications during the first 20 weeks of pregnancy and the use of vitamins, minerals, fatty acids, herbs and other natural products. Women´s attitude and beliefs towards the use of medications was also examined. The study was conducted at the Prenatal Diagnosis Unit at Landspitali from January to April 2017. Women who attended routine ultrasound examination at 20 weeks were offered to participate. A questionnaire was submitted to partici-pants in an interview with the researcher following the doctor's appointment. Of the 213 participants, 90% used medication at least once during the first 20 weeks of pregnancy. Approximately 80% of these medications belong to FASS safety classes A and B and are considered safe during pregnancy. The proportion of women who did not use folic acid was 14% which was associated with residence in rural areas (p=0.03) and younger age (p=0.019). Natural products were used by 14% but information about their safety is lacking. The majority (81%) was satisfied with the information they received when a drug was prescribed and 94% said they had sufficient access to information about medication use during pregnancy. The most commonly used sources of information were the internet (51%) and the local midwive (44%). The use of medications and supplements during pregnancy is common. Most medications being used are considered safe during pregnancy. The majority of pregnant women take folic acid. Pregnant women have a logical and generally a positive attitude towards medication use during pregnancy.

Identifiants

pubmed: 30601122
doi: 10.17992/lbl.2019.01.211
doi:

Substances chimiques

Biological Products 0
Prescription Drugs 0

Types de publication

Journal Article

Langues

ice

Sous-ensembles de citation

IM

Pagination

11-16

Auteurs

Unnur Sverrisdottir (U)

Faculty of Pharmaceutical sciences, The University of Iceland.

Freyja Jonsdottir (F)

Faculty of Pharmaceutical sciences, The University of Iceland, Pharmacy department, The National University Hospital.

Anna Ingibjorg Gunnarsdottir (AI)

Faculty of Pharmaceutical sciences, The University of Iceland, Pharmacy department, The National University Hospital.

Hildur Hardardottir (H)

Obstetrics and gynecology, The National University Hospital, Faculty of Medicine, The University of Iceland.

Ragnheidur Ingibjorg Bjarnadottir (RI)

Faculty of Medicine, The University of Iceland, The Primary health care of the capital area.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH